Wells Fargo & Company Ptc Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,649 shares of PTCT stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,649

Previous 30,837 13.58%

Holding current value

$1.23 Million

Previous $942,000 4.88%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$30.39 - $37.66 $127,273 - $157,720	-4,188 Reduced 13.58%	26,649 $988,000
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $79,798 - $129,667	3,232 Added 11.71%	30,837 $942,000
Q1 2024 May 10, 2024	BUY	$24.15 - $31.95 $52,960 - $70,066	2,193 Added 8.63%	27,605 $803,000
Q4 2023 Feb 09, 2024	SELL	$18.07 - $29.37 $503,900 - $819,011	-27,886 Reduced 52.32%	25,412 $700,000
Q3 2023 Nov 13, 2023	SELL	$22.41 - $41.99 $225,086 - $421,747	-10,044 Reduced 15.86%	53,298 $1.19 Million
Q2 2023 Aug 15, 2023	BUY	$40.4 - $59.1 $946,814 - $1.39 Million	23,436 Added 58.73%	63,342 $2.58 Million
Q1 2023 May 12, 2023	BUY	$38.16 - $48.86 $1.48 Million - $1.89 Million	38,763 Added 3391.34%	39,906 $1.93 Million
Q4 2022 Feb 13, 2023	SELL	$33.53 - $54.79 $62,600 - $102,292	-1,867 Reduced 62.03%	1,143 $43,000
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $34,107 - $43,887	-815 Reduced 21.31%	3,010 $151,000
Q2 2022 Aug 12, 2022	SELL	$25.6 - $45.23 $876,441 - $1.55 Million	-34,236 Reduced 89.95%	3,825 $154,000
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $751,391 - $1.01 Million	-22,544 Reduced 37.2%	38,061 $1.42 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $105,867 - $125,328	2,994 Added 5.2%	60,605 $2.41 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $439,271 - $531,019	11,869 Added 25.95%	57,611 $2.14 Million
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $851,560 - $1.11 Million	-22,439 Reduced 32.91%	45,742 $1.93 Million
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $775,897 - $1.14 Million	-16,579 Reduced 19.56%	68,181 $3.23 Million
Q4 2020 Feb 09, 2021	BUY	$47.96 - $67.64 $893,638 - $1.26 Million	18,633 Added 28.18%	84,760 $5.17 Million
Q3 2020 Nov 05, 2020	SELL	$45.41 - $57.07 $4.66 Million - $5.85 Million	-102,531 Reduced 60.79%	66,127 $3.09 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $1.95 Million - $2.52 Million	45,750 Added 37.22%	168,658 $8.56 Million
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $3.98 Million - $7.3 Million	122,908 New	122,908 $5.48 Million

Others Institutions Holding PTCT

# of Institutions

222

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.29B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ptc Therapeutics, Inc. Transaction History